Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,172.93
(
0.11%
)
US TECH 100
26,536.00
(
-0.07%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
101.63
(
0.09%
)
Bitcoin
76,683.75
(
-2.51%
)
News Focus
News Focus
Post# of 823155
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

HyGro

Send PM Follow Ignore
Followers 24
Posts 4177
Boards Moderated 0
Alias Born 12/18/2019

HyGro

Re: biosectinvestor post# 522830

Tuesday, 10/18/2022 12:23:21 PM

Tuesday, October 18, 2022 12:23:21 PM

Post# of 823155
The Risks as stated by NWBO is a.) confounding of the nOS data and b.) the manipulated protocol, comparator, endpoints and SAP that have not been approved by regulators. That's was NWBO states in their SEC filing. So basically everything about the trial -- validity of the data, and the manipulated trial protocol and rGBM endpoint.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News